Concepedia

Publication | Open Access

SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma

DOIFull Paper Access

572

Citations

21

References

2014

Year

Andrew X. Zhu, Olivier Rosmorduc, T.R. Jeffry Evans, Paul J. Ross, Armando Santoro, Flair José Carrilho, Jordi Bruix, Shukui Qin, Paul J. Thuluvath, Josep M. Llovet,
Journal of Clinical Oncology

Abstract

Adding erlotinib to sorafenib did not improve survival in patients with advanced HCC.

References

YearCitations

Page 1